Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 23.04
+0.28 (1.23%)
Jun 23, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 4.59 billion as of June 23, 2026. Its market cap has decreased by -4.99% in one year.
Market Cap
4.59B
Enterprise Value
4.34B
Revenue
1.74B
Ranking
n/a
PE Ratio
16.06
Stock Price
23.04
Market Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 4.59B, a decrease of -32.81%. That is a compound annual growth rate of -6.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 4.59B | 9.90% |
| Dec 31, 2025 | 4.18B | 151.73% |
| Dec 31, 2024 | 1.66B | -29.78% |
| Dec 29, 2023 | 2.36B | -29.56% |
| Dec 30, 2022 | 3.36B | -29.11% |
| Dec 31, 2021 | 4.73B | 7.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai OPM Biosciences | 5.30B |
| Jiangsu Aidea Pharmaceutical Group | 5.29B |
| Anhui Huaheng Biotechnology | 5.20B |
| Shanghai Serum Bio-Technology | 5.17B |
| Novogene | 5.06B |
| Shenzhen Weiguang Biological Products | 5.03B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.82B |
| PharmaResources (Shanghai) | 4.76B |